344 related articles for article (PubMed ID: 29357322)
1. Hypoxia Suppresses TGF-B1-Induced Cardiac Myocyte Myofibroblast Transformation by Inhibiting Smad2/3 and Rhoa Signaling Pathways.
Yan Z; Shen D; Liao J; Zhang Y; Chen Y; Shi G; Gao F
Cell Physiol Biochem; 2018; 45(1):250-257. PubMed ID: 29357322
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia reduces TGFbeta1-induced corneal keratocyte myofibroblast transformation.
Xing D; Bonanno JA
Mol Vis; 2009 Sep; 15():1827-34. PubMed ID: 19753310
[TBL] [Abstract][Full Text] [Related]
3. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation.
Rizvi F; Siddiqui R; DeFranco A; Homar P; Emelyanova L; Holmuhamedov E; Ross G; Tajik AJ; Jahangir A
Int J Cardiol; 2018 Nov; 270():228-236. PubMed ID: 30220377
[TBL] [Abstract][Full Text] [Related]
5. Cobalt chloride induces RhoA/ROCK activation and remodeling effect in H9c2 cardiomyoblasts: Involvement of PI3K/Akt and MAPK pathways.
Cheng CI; Lee YH; Chen PH; Lin YC; Chou MH; Kao YH
Cell Signal; 2017 Aug; 36():25-33. PubMed ID: 28435089
[TBL] [Abstract][Full Text] [Related]
6. Effect of cAMP on TGFbeta1-induced corneal keratocyte-myofibroblast transformation.
Xing D; Bonanno JA
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):626-33. PubMed ID: 18936144
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
8. Rho plays a key role in TGF-beta1-induced cytoskeletal rearrangement in human retinal pigment epithelium.
Lee J; Ko M; Joo CK
J Cell Physiol; 2008 Aug; 216(2):520-6. PubMed ID: 18314880
[TBL] [Abstract][Full Text] [Related]
9. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
[TBL] [Abstract][Full Text] [Related]
10. [Tofacitinib inhibits the transformation of lung fibroblasts into myofibroblasts through JAK/STAT3 pathway].
He S; Chen X; Cheng Q; Zhu L; Zhang P; Tong S; Xue J; DU Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):505-511. PubMed ID: 38864137
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
12. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
13. Nintedanib inhibits TGF-β-induced myofibroblast transdifferentiation in human Tenon's fibroblasts.
Lin X; Wen J; Liu R; Gao W; Qu B; Yu M
Mol Vis; 2018; 24():789-800. PubMed ID: 30636861
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D attenuates myofibroblast differentiation and extracellular matrix accumulation in nasal polyp-derived fibroblasts through smad2/3 signaling pathway.
Lee SA; Yang HW; Um JY; Shin JM; Park IH; Lee HM
Sci Rep; 2017 Aug; 7(1):7299. PubMed ID: 28779150
[TBL] [Abstract][Full Text] [Related]
15. RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species.
Manickam N; Patel M; Griendling KK; Gorin Y; Barnes JL
Am J Physiol Renal Physiol; 2014 Jul; 307(2):F159-71. PubMed ID: 24872317
[TBL] [Abstract][Full Text] [Related]
16. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation.
Lu Q; Harrington EO; Jackson H; Morin N; Shannon C; Rounds S
J Appl Physiol (1985); 2006 Aug; 101(2):375-84. PubMed ID: 16645187
[TBL] [Abstract][Full Text] [Related]
18. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) decreases the expression of collagen I via TGF-β1/Smad2/3 and subsequently inhibits fibroblast-myofibroblast transition.
Zhou JP; Tang W; Feng Y; Li N; Gu CJ; Li QY; Wan HY
Clin Sci (Lond); 2016 Nov; 130(21):1983-1991. PubMed ID: 27543459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]